Noninvasive Serum Fibrosis Markers for Screening and Staging Chronic Hepatitis C Virus Patients in a Large US Cohort

BACKGROUND: Liver biopsy remains critical for staging liver disease in hepatitis C virus (HCV)–infected persons, but is a bottleneck to evaluation, follow-up, and treatment of HCV. Our analysis sought to validate APRI (aspartate aminotransferase [AST]–to-platelet ratio index) and FIB-4, an index fro...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:Clin Infect Dis
Autores principales: Holmberg, Scott D., Lu, Mei, Rupp, Loralee B., Lamerato, Lois E., Moorman, Anne C., Vijayadeva, Vinutha, Boscarino, Joseph A., Henkle, Emily M., Gordon, Stuart C.
Formato: Artigo
Lenguaje:Inglês
Publicado: 2013
Materias:
Article
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC5672918/
https://ncbi.nlm.nih.gov/pubmed/23592832
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/cit245
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares